title: Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506.
authors.affiliation: Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom.
authors.forename: M
authors.initials: M
authors.lastname: Hossein-Nia
authors.forename: J J
authors.initials: JJ
authors.lastname: Devlin
authors.forename: M
authors.initials: M
authors.lastname: Fagbohun
authors.forename: J M
authors.initials: JM
authors.lastname: Tredger
authors.forename: R
authors.initials: R
authors.lastname: Williams
authors.forename: A
authors.initials: A
authors.lastname: Johnston
authors.forename: D W
authors.initials: DW
authors.lastname: Holt
mesh_terms: D000118:Acetylglucosaminidase / Q000652:urine; D000284:Administration, Oral; D000328:Adult; D015415:Biomarkers / Q000652:urine; D016572:Cyclosporine / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011507:Proteinuria; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D015415:Biomarkers; D016572:Cyclosporine; D000118:Acetylglucosaminidase; D016559:Tacrolimus